Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting balloon; in-stent restenosis; paclitaxel-coated balloon; percutaneous coronary intervention; target lesion failure; BSR; drug-eluting balloon-to-stent ratio; CI; confidence interval; DEB; drug-eluting balloon; DES; drug-eluting stent(s)
مقالات ISI آسیب دیدگی هدف مجدد مجدد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آسیب دیدگی هدف مجدد مجدد; bifurcation lesion; left main coronary artery; percutaneous coronary intervention; ACS; acute coronary syndrome(s); CABG; coronary artery bypass; C-DES; current-generation drug-eluting stent(s); CI; confidence interval; CKD; chronic kidney disease; DES; d
Keywords: آسیب دیدگی هدف مجدد مجدد; new-generation drug-eluting stents; patient-level pooled analysis of women; percutaneous coronary intervention; stent length per lesion; stent length per patient; CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; ha
Keywords: آسیب دیدگی هدف مجدد مجدد; biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
Keywords: آسیب دیدگی هدف مجدد مجدد; DES; drug-eluting stents; TLR; target lesion revascularization; VL-TLR; very late target lesion revascularization; ACS; acute coronary syndrome; SES; sirolimus-eluting stent; CAG; coronary angiography; MLD; minimum lumen diameter; LLL; late lumen loss; Si
Keywords: آسیب دیدگی هدف مجدد مجدد; ACS; acute coronary syndrome; BARC; Bleeding Academic Research Consortium; BMS; Bare metal stent; BP-BES; biodegradable polymer coated biolimus-A9 eluting stents; BP-SES; biodegradable polymer coated sirolimus eluting stents; BVS; bioresorbable vascular s
Keywords: آسیب دیدگی هدف مجدد مجدد; BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting balloons; long lesions; superficial femoral artery disease; 24Â months; CI; confidence interval; PCB; paclitaxel-coated balloon; PTA; percutaneous transluminal angioplasty; SFA; superficial femoral artery; TASC; TransAtlantic Inter-Society Co
Keywords: آسیب دیدگی هدف مجدد مجدد; bioresorbable vascular scaffolds; complex coronary lesions; long coronary lesions; vascular reparative therapy; BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; MI; m
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-coated balloon; femoropopliteal artery; in-stent restenosis; paclitaxel; peripheral artery disease; ABI; ankle-brachial index; CD; clinically driven; DCB; drug-coated balloon; DES; drug-eluting stent(s); DUS; duplex ultrasonography; ISR; in-stent res
Keywords: آسیب دیدگی هدف مجدد مجدد; BMS; bare metal stent; CE; combined evidence; CLI; critical limb ischemia; CMS; covered metal stent; cRCT; constructed randomized controlled trial; CrI; credible interval; CTO; chronic total occlusion; DCB; drug-coated balloon; DES; drug-eluting stent; NM
Keywords: آسیب دیدگی هدف مجدد مجدد; Drug-coated balloon; Drug-eluting balloon; In-stent restenosis; Percutaneous coronary intervention; Paclitaxel; Ballon médicamenté; Athérosclérose; Resténose intra-stent; Angioplastie percutanée; Paclitaxel; AMI; acute myocardial infarction; BMS; ba
Keywords: آسیب دیدگی هدف مجدد مجدد; DES; drug-eluting stent; TLR; target lesion revascularization; SES; sirolimus-eluting stent; ACS; acute coronary syndrome; PCI; percutaneous coronary intervention; SCAD; stable coronary artery disease; RD; reference diameter; MLD; minimum lumen diameter;
Keywords: آسیب دیدگی هدف مجدد مجدد; Drug-coated balloons; In stent restenosis; Target lesion revascularization; Angioplasty;
Keywords: آسیب دیدگی هدف مجدد مجدد; PTCA; percutaneous transluminal coronary angioplasty; DES; drug-eluting metallic stents; BVS; bioresorbable vascular scaffold; OCT; optical coherence tomography; PCI; percutaneous coronary intervention; TLR; target lesion revascularization; DAPT; dual ant
Keywords: آسیب دیدگی هدف مجدد مجدد; ABI; ankle brachial index; ACT; activated clotting time; INR; international normalized ratio; MAE; major adverse event; PTA; percutaneous transluminal angioplasty; TLR; target lesion revascularization; WIQ; Walking Impairment Questionnaire;
Keywords: آسیب دیدگی هدف مجدد مجدد; ISR; in-stent restenosis; OR; odds ratio; TLR; target lesion revascularization;
Keywords: آسیب دیدگی هدف مجدد مجدد; Percutaneous coronary intervention; In-stent restenosis; Neointimal hyperplasia; Target vessel revascularization; Target lesion revascularization;
Keywords: آسیب دیدگی هدف مجدد مجدد; CI; confidence interval; CLI; chronic limb ischemia; HR; hazard ratio; OS; overall survival; PTA; percutaneous transluminal angioplasty; SFA; superficial femoral artery; TLR; target lesion revascularization;
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study
Keywords: آسیب دیدگی هدف مجدد مجدد; ULMCA; unprotected left main coronary artery; PS; provisional stenting strategy; E2S; elective two-stent strategy; MACEs; major adverse cardiac events; TLR; target lesion revascularization; Unprotected left main coronary artery; True bifurcation lesions;
12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-coated balloon; drug-eluting balloon; femoropopliteal segment; late lumen loss; paclitaxel; patency; peripheral artery disease; peripheral vascular diseases; popliteal artery; restenosis; stenosis; superficial femoral artery; ABI; ankle-brachial in
Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels-Results from the Zilver PTX Japan Post-Market Surveillance Study
Keywords: آسیب دیدگی هدف مجدد مجدد; ABI; ankle-brachial index; CLI; critical limb ischemia; DES; drug-eluting stent; ISR; in-stent restenosis; PAD; peripheral artery disease; TLR; target lesion revascularization;
1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stent(s); Eluvia; long femoropopliteal lesions; paclitaxel; paclitaxel-eluting stent(s); peripheral arterial disease; CLTI; critical limb-threatening ischemia; DCB; drug-coated balloon; PES; paclitaxel-eluting stent(s); POBA; plain old balloo
New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome
Keywords: آسیب دیدگی هدف مجدد مجدد; fractional flow reserve; optical coherence tomography; restenosis; stent expansion; CM; conventional methodology; DES; drug-eluting stent(s); DoCE; device-oriented composite endpoint; FFR; fractional flow reserve; MEI; minimum expansion index; MSA; minima
Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation
Keywords: آسیب دیدگی هدف مجدد مجدد; bioresorbable vascular scaffold; neoatherosclerosis; optical coherence tomography; AI; asymmetry index; BVS; bioresorbable vascular scaffold; CT; computed tomography; DES; drug-eluting stent(s); EI; eccentricity index; IVUS; intravascular ultrasound; NTG
Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy
Keywords: آسیب دیدگی هدف مجدد مجدد; CABG; Coronary artery bypass graft; DCV%; Percent dense calcium volume; DES; Drug-eluting stents; EEM; External elastic membrane; IVUS; Intravascular ultrasound; PCI; Percutaneous coronary intervention; STEMI; ST-segment elevation myocardial infarction; T
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold
Keywords: آسیب دیدگی هدف مجدد مجدد; bioresorbable; coronary; scaffold; sirolimus-eluting; BRS; bioresorbable scaffold; DES; drug-eluting stent(s); ITT; intention-to-treat; LLL; late lumen loss; MACE; major adverse cardiac events(s); MI; myocardial infarction; MLD; minimum lumen diameter; P
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: آسیب دیدگی هدف مجدد مجدد; restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stent; percutaneous coronary intervention; Resolute zotarolimus-eluting stent; stent thrombosis; ARC; Academic Research Consortium; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarction; R-ZES; Resolute zotaro
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stent(s); percutaneous coronary intervention; reference vessel diameter; Resolute Onyx; restenosis; stent(s); zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary
The ReACT Trial
Keywords: آسیب دیدگی هدف مجدد مجدد; angiographic follow-up; percutaneous coronary intervention; prognosis; stent(s); ACS; acute coronary syndrome(s); AMI; acute myocardial infarction; DES; drug-eluting stent(s); FUCAG; follow-up coronary angiography; HF; heart failure; IQR; interquartile ra
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
Keywords: آسیب دیدگی هدف مجدد مجدد; angioplasty; coronary disease; stent thrombosis; survival; CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; MACE; major adverse cardiac event(s); MI; myocardial infarction; TLR; target lesion revascularization;
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease
Keywords: آسیب دیدگی هدف مجدد مجدد; coronary artery disease; drug-eluting stent(s); percutaneous coronary intervention; stent design; CABG; coronary artery bypass grafting; CI; confidence interval; CoCr-EES; cobalt chromium everolimus-eluting stent(s); HR; hazard ratio; LL; long lesions; MI
Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease
Keywords: آسیب دیدگی هدف مجدد مجدد; bioresorbable scaffold; coronary artery disease; percutaneous coronary intervention; BRS; bioresorbable scaffold(s); DAPT; dual-antiplatelet therapy; DES; drug-eluting metal stent(s); eBRS; everolimus-eluting bioresorbable scaffold(s); MACE; major adverse
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis)
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting balloon; extended release; in-stent restenosis; porous angioplasty balloon; sirolimus nanoparticle; BMS; bare-metal stent(s); DES; drug-eluting stent(s); ISR; in-stent restenosis; ITT; intention to treat; LLL; late lumen loss; MACE; major adv
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stent(s); drug-filled stent(s); percutaneous coronary intervention; polymer-free stent; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); DFS; drug-filled stent(s); IVUS; intravascular ultrasound; MI; myoc
The DELTA 2 Registry
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stents; left main coronary artery; CABG; coronary artery bypass grafting; CI; confidence interval; CVA; cerebrovascular accident; DES; drug-eluting stent(s); HR; hazard ratio; MACCE; major adverse cardiac and cerebrovascular events(s); MI; my
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease
Keywords: آسیب دیدگی هدف مجدد مجدد; biolimus; drug-eluting; polymer; randomized clinical trial; stent; zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary intervention; ST; stent thrombosis; TLR; target lesion
Self-Expanding Versus Balloon-Expandable Stents for Iliac Artery Occlusive Disease
Keywords: آسیب دیدگی هدف مجدد مجدد; balloon-expandable stent(s); common iliac artery; external iliac artery; peripheral artery disease; randomized trial; self-expanding stent(s); BE; balloon-expandable stent(s); CI; confidence interval; DUS; duplex ultrasound; MAVE; major adverse vascular e
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
Current Interventions for the Left Main Bifurcation
Keywords: آسیب دیدگی هدف مجدد مجدد; bifurcation; left main; stenting techniques; CABG; coronary artery bypass grafting; DES; drug-eluting stent(s); DK; double kissing; FFR; fractional flow reserve; FKB; final kissing balloon; HRPCI; high-risk percutaneous coronary intervention; IABP; intra-
Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry
Keywords: آسیب دیدگی هدف مجدد مجدد; ACS; acute coronary syndrome; ARC; Academic Research Consortium; BD-DES; biodurable polymer coated drug-eluting stent; BR-DES; bioresorbable polymer coated drug eluting stent; BMS; bare metal stent; CVA; cerebrovascular accidents; DEB; drug-eluting balloo
Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography
Keywords: آسیب دیدگی هدف مجدد مجدد; AO; adjacent to the ostium; DES; drug eluting stents; EES; everolimus-eluting stents; EF; ejection fraction; KBT; kissing-balloon technique; LAD; left anterior descending artery; LCx; left circumflex artery; NIH; neointimal hyperplasia; OCT; optical coher
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French “real-world” prospective GARO Registry
Keywords: آسیب دیدگی هدف مجدد مجدد; Drug-eluting stent in-stent restenosis; Paclitaxel-coated balloon; Target lesion revascularization;
Local Ultrasound to Enhance Paclitaxel Delivery After Femoral-Popliteal Treatment in Critical Limb Ischemia
Keywords: آسیب دیدگی هدف مجدد مجدد; critical limb ischemia; femoral-popliteal artery disease; paclitaxel; ultrasound; BTK; below-the-knee; CLI; critical limb ischemia; DEB; drug-eluting balloon; DSA; digital subtraction angiography; DUS; duplex ultrasonography; FU; follow-up; MI; myocardial
Retrospective Multicenter Comparison of S.M.A.R.T. CONTROL and MISAGO Stents in Treatment of Femoropopliteal Lesions
Keywords: آسیب دیدگی هدف مجدد مجدد; CI; confidence interval; TASC; Trans-Atlantic Inter-Society of Consensus; TLR; target lesion revascularization;
Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II)
Keywords: آسیب دیدگی هدف مجدد مجدد; DES; drug-eluting stent; MACE; major adverse cardiac events; MI; myocardial infarction; PCI; percutaneous coronary intervention; POCE; patient-oriented clinical endpoint; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel
Acotec Drug-Coated Balloon Catheter
Keywords: آسیب دیدگی هدف مجدد مجدد; drug-coated balloon catheter; femoropopliteal disease; randomized clinical trial; restenosis inhibition; ABI; ankle-brachial index; DCB; drug-coated balloon; LLL; late lumen loss; TLR; target lesion revascularization;
Contemporary Approach to Coronary Bifurcation Lesion Treatment
Keywords: آسیب دیدگی هدف مجدد مجدد; bench testing; coronary bifurcation; provisional side branch stenting strategy; proximal stent optimization; 2-stent techniques; wall shear stress; BIF; coronary bifurcation; BRS; bioresorbable scaffolds; DCB; drug-coated balloon; DES; drug-eluting stent(
Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial
Keywords: آسیب دیدگی هدف مجدد مجدد; BMS; bare-metal stents; CAC; coronary artery calcification; CAD; coronary artery disease; DES; drug-eluting stents; IVUS; intravascular ultrasound; MACE; major adverse cardiovascular events; MI; myocardial infarction; OA; orbital atherectomy; OAD; orbital